WO2004071392A8 - Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4) - Google Patents
Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4)Info
- Publication number
- WO2004071392A8 WO2004071392A8 PCT/EP2004/000784 EP2004000784W WO2004071392A8 WO 2004071392 A8 WO2004071392 A8 WO 2004071392A8 EP 2004000784 W EP2004000784 W EP 2004000784W WO 2004071392 A8 WO2004071392 A8 WO 2004071392A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diseases
- disorders
- muscarinic
- therapeutics
- diagnostics
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1787—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03002647 | 2003-02-11 | ||
EP03002647.0 | 2003-02-11 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2004071392A2 WO2004071392A2 (en) | 2004-08-26 |
WO2004071392A8 true WO2004071392A8 (en) | 2004-10-14 |
WO2004071392A3 WO2004071392A3 (en) | 2005-01-06 |
Family
ID=32864920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/000784 WO2004071392A2 (en) | 2003-02-11 | 2004-01-29 | Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4) |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2004071392A2 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2223588T3 (en) * | 1999-10-13 | 2005-03-01 | Banyu Pharmaceutical Co., Ltd. | IMIDAZOLIDINONA SUBSTITUTED DERIVATIVES. |
WO2002036609A2 (en) * | 2000-10-31 | 2002-05-10 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the chrm4 gene |
-
2004
- 2004-01-29 WO PCT/EP2004/000784 patent/WO2004071392A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2004071392A3 (en) | 2005-01-06 |
WO2004071392A2 (en) | 2004-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004042389A3 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d) | |
WO2005040828A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 49 (gpr49) | |
WO2004080373A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2) | |
WO2003093816A3 (en) | Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) | |
WO2004042402A3 (en) | Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) | |
WO2004008153A3 (en) | Diagnostics and therapeutics for diseases associated with homo sapiens putative neurotransmitter receptor (pnr) | |
WO2003065044A3 (en) | Diagnostics and therapeutics for diseases associated with gpr72 | |
WO2003095967A3 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9) | |
WO2004082568A3 (en) | Diagnostics and therapeutics for diseases associated with complement component 5a receptor (c5ar) | |
WO2004038405A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) | |
WO2004071392A8 (en) | Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4) | |
WO2004071378A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) | |
WO2003096020A3 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8) | |
WO2003066077A3 (en) | Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) | |
WO2004104577A3 (en) | Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 4 (5-ht4) | |
WO2004038421A3 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41) | |
WO2003083135A3 (en) | Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) | |
WO2003100433A3 (en) | Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3) | |
WO2004082566A3 (en) | Diagnostics and therapeutics for diseases associated with complement component 3a receptor 1 (c3ar1) | |
WO2003100435A3 (en) | Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2) | |
WO2004042405A3 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3) | |
WO2004071394A3 (en) | Diagnostics and therapeutics for diseases associated with hm74 | |
WO2003100436A3 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 10 (ccr10) | |
WO2004015427A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 19 (gpr19) | |
WO2004057328A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor 38 (gpr38) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 35/2004 UNDER (30) REPLACE "Ä3002647.0" BY "03002647.0" |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |